CI-1033, a pan-erbB tyrosine kinase inhibitor
Year: 2001
Type: article
Source: Seminars in Oncology
Institution: Pfizer (United States)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2150059798
